Quick Answer
Intellia Therapeutics, Inc. reported Total Assets of $842.13 million for fiscal year 2025.
Intellia Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $842.13M | -29.3% |
| 2024 | $1.19B | -8.5% |
| 2023 | $1.30B | -14.4% |
| 2022 | $1.52B | +17.4% |
| 2021 | $1.29B | +91.4% |
| 2020 | $676.32M | +102.3% |
| 2019 | $334.28M | -3.8% |
| 2018 | $347.31M | -7.7% |
| 2017 | $376.24M | +25.8% |
| 2016 | $298.97M | +264.0% |
| 2015 | $82.14M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $925.27M | -21.1% | +2.9% |
| June 30, 2025 | $898.89M | -24.6% | -8.8% |
| March 31, 2025 | $986.16M | -21.7% | -17.2% |
| December 31, 2024 | $1.19B | -8.5% | +1.5% |
| September 30, 2024 | $1.17B | -5.6% | -1.5% |
| June 30, 2024 | $1.19B | -10.0% | -5.4% |
| March 31, 2024 | $1.26B | -11.2% | -3.2% |
| December 31, 2023 | $1.30B | -14.4% | +4.6% |
- Intellia Therapeutics, Inc. showed a decrease of -29.3% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Intellia Therapeutics, Inc.’s total assets has grown by 925.2% (from $82.14 million to $842.13 million).
- The most recent figure is from Intellia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: